109 related articles for article (PubMed ID: 20375624)
21. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.
Jin T; Bokarewa M; Foster T; Mitchell J; Higgins J; Tarkowski A
J Immunol; 2004 Jan; 172(2):1169-76. PubMed ID: 14707093
[TBL] [Abstract][Full Text] [Related]
22. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.
Wilson CL; Ouellette AJ; Satchell DP; Ayabe T; López-Boado YS; Stratman JL; Hultgren SJ; Matrisian LM; Parks WC
Science; 1999 Oct; 286(5437):113-7. PubMed ID: 10506557
[TBL] [Abstract][Full Text] [Related]
23. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease.
Cunliffe RN; Rose FR; Keyte J; Abberley L; Chan WC; Mahida YR
Gut; 2001 Feb; 48(2):176-85. PubMed ID: 11156637
[TBL] [Abstract][Full Text] [Related]
24. Characterization of luminal paneth cell alpha-defensins in mouse small intestine. Attenuated antimicrobial activities of peptides with truncated amino termini.
Ouellette AJ; Satchell DP; Hsieh MM; Hagen SJ; Selsted ME
J Biol Chem; 2000 Oct; 275(43):33969-73. PubMed ID: 10942762
[TBL] [Abstract][Full Text] [Related]
25. Human Defensin-5 Blocks Ethanol and Colitis-Induced Dysbiosis, Tight Junction Disruption and Inflammation in Mouse Intestine.
Shukla PK; Meena AS; Rao V; Rao RG; Balazs L; Rao R
Sci Rep; 2018 Nov; 8(1):16241. PubMed ID: 30389960
[TBL] [Abstract][Full Text] [Related]
26. Localization of human intestinal defensin 5 in Paneth cell granules.
Porter EM; Liu L; Oren A; Anton PA; Ganz T
Infect Immun; 1997 Jun; 65(6):2389-95. PubMed ID: 9169779
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial peptides and colitis.
Ho S; Pothoulakis C; Koon HW
Curr Pharm Des; 2013; 19(1):40-7. PubMed ID: 22950497
[TBL] [Abstract][Full Text] [Related]
28. Impact of pro segments on the folding and function of human neutrophil alpha-defensins.
Wu Z; Li X; Ericksen B; de Leeuw E; Zou G; Zeng P; Xie C; Li C; Lubkowski J; Lu WY; Lu W
J Mol Biol; 2007 Apr; 368(2):537-49. PubMed ID: 17355880
[TBL] [Abstract][Full Text] [Related]
29. Defensins and mucosal protection.
Mahida YR; Cunliffe RN
Novartis Found Symp; 2004; 263():71-7; discussion 77-84, 211-8. PubMed ID: 15669635
[TBL] [Abstract][Full Text] [Related]
30. Human Paneth cell α-defensin-5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice.
Larsen IS; Fritzen AM; Carl CS; Agerholm M; Damgaard MTF; Holm JB; Marette A; Nordkild P; Kiens B; Kristiansen K; Wehkamp J; Jensen BAH
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E42-E52. PubMed ID: 30860877
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of bactericidal activity is maintained in a mouse alpha-defensin precursor with proregion truncations.
Figueredo SM; Ouellette AJ
Peptides; 2010 Jan; 31(1):9-15. PubMed ID: 19837119
[TBL] [Abstract][Full Text] [Related]
32. A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions.
Wilson SS; Tocchi A; Holly MK; Parks WC; Smith JG
Mucosal Immunol; 2015 Mar; 8(2):352-61. PubMed ID: 25118165
[TBL] [Abstract][Full Text] [Related]
33. An Experimental Approach to Rigorously Assess Paneth Cell α-Defensin (Defa) mRNA Expression in C57BL/6 Mice.
Castillo PA; Nonnecke EB; Ossorio DT; Tran MTN; Goley SM; Lönnerdal B; Underwood MA; Bevins CL
Sci Rep; 2019 Sep; 9(1):13115. PubMed ID: 31511628
[TBL] [Abstract][Full Text] [Related]
34. Paneth cell trypsin is the processing enzyme for human defensin-5.
Ghosh D; Porter E; Shen B; Lee SK; Wilk D; Drazba J; Yadav SP; Crabb JW; Ganz T; Bevins CL
Nat Immunol; 2002 Jun; 3(6):583-90. PubMed ID: 12021776
[TBL] [Abstract][Full Text] [Related]
35. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.
Salzman NH; Underwood MA; Bevins CL
Semin Immunol; 2007 Apr; 19(2):70-83. PubMed ID: 17485224
[TBL] [Abstract][Full Text] [Related]
36. Paneth cells and innate immunity in the crypt microenvironment.
Ouellette AJ
Gastroenterology; 1997 Nov; 113(5):1779-84. PubMed ID: 9352884
[TBL] [Abstract][Full Text] [Related]
37. Reduction Impairs the Antibacterial Activity but Benefits the LPS Neutralization Ability of Human Enteric Defensin 5.
Wang C; Shen M; Zhang N; Wang S; Xu Y; Chen S; Chen F; Yang K; He T; Wang A; Su Y; Cheng T; Zhao J; Wang J
Sci Rep; 2016 Mar; 6():22875. PubMed ID: 26960718
[TBL] [Abstract][Full Text] [Related]
38. Hydrophobic determinants of α-defensin bactericidal activity.
Tai KP; Le VV; Selsted ME; Ouellette AJ
Infect Immun; 2014 Jun; 82(6):2195-202. PubMed ID: 24614658
[TBL] [Abstract][Full Text] [Related]
39. alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.
Tsvetkova EV; Aleshina GM; Shamova OV; Leonova LE; Lehrer RI; Kokryakov VN
Biochemistry (Mosc); 2006 Aug; 71(8):879-83. PubMed ID: 16978151
[TBL] [Abstract][Full Text] [Related]
40. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]